Results 181 to 190 of about 1,503,737 (251)

Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Rheumatoid arthritis (RA) is associated with an increased risk of frailty and osteoporosis, but the relationship between frailty and incident osteoporotic fractures in RA is underexplored. Methods Data were from the Veterans Affairs (VA) Rheumatoid Arthritis Registry. Frailty was measured using the VA Frailty Index (VAFI).
Katherine D. Wysham, Hannah F. Brubeck, Aaron Baraff, Punyasha Roul, Namrata Singh, James S. Andrews, Grant W. Cannon, Gary A. Kunkel, Ted R. Mikuls, Bryant R. England, Dolores M. Shoback, Patricia P. Katz, Jose M. Garcia, Ariela R. Orkaby, Joshua F. Baker   +14 more
wiley   +1 more source

In-silico screening of anti-cancer natural compounds targeting NF-κB as identification of potential therapeutic inhibitor. [PDF]

In Silico Pharmacol
Tasnim J, Hasan MM, Fatima Q, Rashid L, Sarker S, Hossain KR, Nisar M, Molla MTH, Shafiq MI, Alam MT.   +9 more
europepmc   +1 more source

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

Arthritis Care &Research, Accepted Article.
Objective VEXAS syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures. A VEXAS‐specific disease activity index (DAI) is an essential tool for reliably capturing changes in disease ...
Kevin Byram, Heřman Mann, Danielle Hammond, Onima Chowdhury, Sinisa Savic, Yohei Kirino, Carmelo Gurnari, Maël Heiblig, Thibault Comont, Arsène Mekinian, Mrinal M. Patnaik, Lachelle D. Weeks, Gary Ho, Adam Al‐Hakim, Scott Goldberg, Marcela A. Ferrada, Sophie Georgin‐Lavialle, Peter C. Grayson, Emma M. Groarke, Bhavisha Patel, Megan Sullivan, Sarah A. Buckley, Bryan G. Harder, Raman Garcha, David B. Beck, Matthew J. Koster   +25 more
wiley   +1 more source

Correction: Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid. [PDF]

Front Mol Biosci
Ferraro G, Belvedere R, Petrella A, Tosco A, Stork B, Salamone S, Minassi A, Pollastro F, Morretta E, Monti MC.   +9 more
europepmc   +1 more source

Employment Trajectories of Patients with Systemic lupus erythematosus (SLE) and Factors Driving Transitions Between States

Arthritis Care &Research, Accepted Article.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Materials and Methods Using data from a single center, we analyzed employment transitions, adjusted mean ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source

Predictive topological modeling of the structure-property relationships in naturally occurring anti-cancer chalcones. [PDF]

Sci Rep
Obaid AAR, Hakeem A, Ullah A, Zaman S, Ahmad H, Ali P, Belay MB.   +6 more
europepmc   +1 more source

Fenofibrate as an anti-cancer treatment: an in vitro study on glioblastoma cells at various oxygen levels and on normal astrocytes. [PDF]

Cancer Cell Int
Chokry Y, Groo AC, Corvaisier S, Ben Hadj Hassen O, Blanchard I, Valable S, Malzert-Fréon A.   +6 more
europepmc   +1 more source

A bacterial toxin as a novel anti-cancer drug modulating the tumor-microenvironment. [PDF]

Cell Death Dis
Li L, Evain P, Phillips MT, Chiloeches ML, Bergonzini A, Frisan T, Wai SN, Erttmann SF.   +7 more
europepmc   +1 more source

Improvements of an oral anti-cancer drug safety management program for patients with cancer. [PDF]

Asia Pac J Oncol Nurs
Yang H, Zhang H, Zhou J, Li H, Guo R, Zhang H, You M, Zhang L, Liu W, Lu Y.   +9 more
europepmc   +1 more source

Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells. [PDF]

Sci Rep
Trybus W, Trybus E, Król T.
europepmc   +1 more source